Fig. 1From: Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Non-small-cell lung cancer showing spatial variation in staining for angiogenesis (CD34), pimonidazole (hypoxia), and glucose transporter protein expression (Glut-1)Back to article page